UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037246
Receipt number R000042472
Scientific Title Analysis of mechanisms for hyper lymphocytic activation in sysytemic lupus erhythematosus
Date of disclosure of the study information 2019/07/04
Last modified on 2019/07/03 10:48:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of mechanisms for hyper lymphocytic activation in sysytemic lupus erhythematosus

Acronym

Analysis of mechanisms for hyper lymphocytic activation in sysytemic lupus erhythematosus

Scientific Title

Analysis of mechanisms for hyper lymphocytic activation in sysytemic lupus erhythematosus

Scientific Title:Acronym

Analysis of mechanisms for hyper lymphocytic activation in sysytemic lupus erhythematosus

Region

Japan


Condition

Condition

systemic lupus erhythema tosus

Classification by specialty

Clinical immunology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To elucidate mechanisms of hyper lymphocytic activation in sysytemic lupus erhythematosus

Basic objectives2

Others

Basic objectives -Others

To elucidate mechanisms of hyper lymphocytic activation in sysytemic lupus erhythematosus

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Identification of molecules related with hyper lymphocytic activation in sysytemic lupus erhythematosus.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Other

Interventions/Control_1

Taking blood from the subjectives annually

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

Systemic lupus erhythematosus
Normal healthy controls
Disease control
(Scleroderma, rheumatoid arthritis, and primary Sjogren's syndrome)

Key exclusion criteria

Person not agreed with enrollment to this study.

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Kazuhisa
Middle name
Last name Nozawa

Organization

Juntendo University

Division name

Department of Rheumatology

Zip code

1138421

Address

2-1-1 Hongo, Bunkyo word, Tokyo

TEL

03-3813-3111

Email

k-nozawa@juntendo.ac.jp


Public contact

Name of contact person

1st name Kazuhisa
Middle name
Last name Nozawa

Organization

Juntendo University

Division name

Department of Rheumatology

Zip code

1138421

Address

2-1-1 Hongo, Bunkyo word, Tokyo

TEL

03-3813-3111

Homepage URL


Email

k-nozawa@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University

Institute

Department

Personal name



Funding Source

Organization

Juntendo University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Juntendo University

Address

2-1-1, Hongo, Bunkyo word, Tokyo

Tel

03-3813-3111

Email

k-nozawa@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

順天堂大学附属順天堂医院


Other administrative information

Date of disclosure of the study information

2019 Year 07 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2019 Year 07 Month 04 Day

Date of IRB


Anticipated trial start date

2019 Year 07 Month 04 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 07 Month 03 Day

Last modified on

2019 Year 07 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042472


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name